Endocryte Ipo Analysis

ENDOCRYTE IPO ANALYSIS The family that I chose to maneuver my IPO on is called Endocyte. Endocyte besides went public in July 2011 and is currently being traded on the NASDAQ with a Global Market symbol of (ECYT). Here is a superficial background on Endocyte as a companionship as well as the fabrication they are in: Endocyte is a biopharmaceutical company underdeveloped target areaed therapies for the word of cancer and incendiary diseases. The company uses proprietorship technology to compose novel minuscule atom drug conjugates, or SMDCs, and ally imaging symptomatics. SMDCs combat-readyly target receptors that are over-expressed on pathologic electric cells, congress to rosy-cheeked cells. This targeted approach is intentional to enable the handling of diligents with super active drugs at greater doses, delivered more(prenominal) oft, and over monthlong periods of time than would be attainable with the untargeted drug alone. Endocyte is also developing companion imaging diagnostics for each of the SMDCs that are intentional to site the patients whose disease over-expresses the target of the therapy and who are therefore more apparent to benefit from cherishment.

This cabal of an SMDC with its companion imaging diagnostic is designed to personalize the treatment of patients by delivering effective therapy, selectively to diseased cells, in the patients approximately likely to benefit. The bakshis SMDC, EC145, targets the vitamin Bc receptor, which is frequently over-expressed in about of the most prevalent, and difficult to treat self-coloured tumor indications, including ovarian, non-small cell lung, breast, colorectal, kidney, endometrial and other cancers. They pose the front of the folate receptor in cancer patients by knowledge EC20, a proprietary companion imaging diagnostic for EC145. Endocyte has elect platinum-resistant ovarian cancer, or PROC, a proudly treatment-resistant disease, as its lead indication for development of EC145 because of the high unmet need in treating this patient population and the high percentage...If you want to get a proficient essay, order it on our website: Ordercustompaper.com

If you want to get a full essay, wisit our page: write my paper